Scinovex
review Open AccessTop 1% cited

Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders

Alimentary Pharmacology & Therapeutics · 2018 · Vol. 48(1) · pp. 15–34
Paul A. GillMenno C. van ZelmJane G. MuirPeter R. Gibson

Abstract

There is a large array of potential disease-modulating effects of SCFA. Adequate targeted delivery to the sites of action is the main limitation of such application. The ongoing development and evaluation of novel delivery techniques offer potential for translating promise to therapeutic benefit.

Helicobacter pylori-related gastroenterology studiesGut microbiota and healthGastrointestinal motility and disordersButyrateMedicineImmune systemShort-chain fatty acidPropionateDiseaseInflammatory bowel diseaseBioinformaticsInflammationImmunology

MeSH terms

Gastrointestinal MicrobiomeAnimalsDietary FatsDietary FiberFatty Acids, VolatileGastrointestinal DiseasesHumansInflammationGastrointestinal Tract

Funding

  • Celgene
  • Danone
  • Monash University
  • Allergan
  • National Health and Medical Research Council
Citations
495
FWCI
42.61
field-weighted impact
References
223
Percentile
100%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.